OrbiMed’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

OrbiMed’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,425,225	Closed	-$272M	–	144
2019 Q1	$272M	Hold	10,425,225	–	–	4.21%	3
2018 Q4	$123M	Hold	10,425,225	–	–	2.27%	11
2018 Q3	$116M	Hold	10,425,225	–	–	1.4%	22
2018 Q2	$137M	Hold	10,425,225	–	–	1.64%	13
2018 Q1	$158M	Hold	10,425,225	–	–	1.96%	12
2017 Q4	$198M	Hold	10,425,225	–	–	2.5%	10
2017 Q3	$176M	Buy	+10,425,225	New	+$170M	1.68%	17

OrbiMed's CMTA Position: Q2 2019 in Review

OrbiMed sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 10,425,225 shares — an estimated $272M sold.

OrbiMed first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $272M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

OrbiMed reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
OrbiMed sold 10,425,225 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $272M.
OrbiMed first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
OrbiMed's Clementia Pharmaceuticals Inc. position peaked at $272M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on OrbiMed's 13F filing for Q2 2019, filed 14 Aug 2019.